UK markets open in 3 hours 20 minutes

Xenon Pharmaceuticals Inc. (XENE)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
38.98-1.44 (-3.56%)
At close: 04:00PM EDT
38.98 0.00 (0.00%)
After hours: 04:20PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Total revenue
0
0
9,434
18,437
32,166
-
Cost of revenue
0
-
-
-
-
0
Gross profit
3,500
-
-
-
-
6,829
Operating expenses
Research development
172,246
167,512
105,767
75,463
50,523
-
Selling general and administrative
51,798
46,542
32,810
21,967
12,944
-
Total operating expenses
224,044
214,054
138,577
97,430
63,467
-
Operating income or loss
-224,044
-214,054
-129,143
-78,993
-31,301
-
Interest expense
-
-
0
0
484
1,434
Total other income/expenses net
1,725
3,749
-4,825
-361
412
-
Income before tax
-188,767
-182,685
-125,255
-78,888
-29,094
-
Income tax expense
-170
-292
118
-6
-257
-
Income from continuing operations
-188,597
-182,393
-125,373
-78,882
-28,837
-
Net income
-188,597
-182,393
-125,373
-78,882
-28,837
-
Net income available to common shareholders
-188,597
-182,393
-124,936
-77,087
-28,013
-
Basic EPS
-2.66
-2.73
-2.06
-1.77
-0.81
-
Diluted EPS
-2.66
-2.73
-2.06
-1.77
-0.81
-
Basic average shares
65,811
66,889
60,542
43,627
34,542
-
Diluted average shares
65,811
66,889
60,542
43,627
34,542
-